{
  "meta": {
    "title": "Thyroid_Part_1",
    "url": "https://brainandscalpel.vercel.app/thyroid-part-1-98c0658e.html",
    "scrapedAt": "2025-11-30T11:13:22.905Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Graves' disease</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Sick thyroid syndrome</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">De Quervain's thyroiditis</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Hashimoto's thyroiditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 41-year-old woman presents with palpitations and heat intolerance. On examination, her pulse is 90/min, and a small, diffuse goitre is noted, which is tender to touch. Thyroid function tests show the following:<br>Free T4 24 pmol/l(8-20)<br>TSH < 0.05 mu/l(0.5-4.5)<br>What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1188528",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188528,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Thyrotoxicosis with tender goitre = subacute (De Quervain's) thyroiditis</strong></li>\n<li>Whilst <strong>Graves' disease</strong> is the most common cause of thyrotoxicosis, it would not cause a tender goitre. <strong>(Option A ruled out)</strong></li>\n<li>In the context of thyrotoxicosis, this finding is specific for <strong>De Quervain's thyroiditis.</strong></li>\n<li><strong>Hashimoto's thyroiditis</strong> is an autoimmune disorder of the thyroid gland. It is typically associated with hypothyroidism, although there may be a transient thyrotoxicosis in the acute phase(Hashitoxicosis). The goitre is <strong>non-tender</strong> in Hashimoto's. <strong>(Option D ruled out)</strong></li>\n</ul>\n<p><strong>Comparison of Thyroiditis Types</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240422520da2d9-3e89-4353-8cc4-9859d8bd7202.jpg\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Sick euthyroid syndrome (Option B)</strong> (Non-thyroidal illness syndrome): Seen in <strong>severe systemic illness</strong> (sepsis, trauma, major surgery, starvation). Lab findings: low T3 (due to reduced peripheral conversion), normal or low T4, and variable TSH.<br /> The thyroid gland is <strong>normal in size and painless</strong>. Since our patient has a <strong>goiter and tenderness</strong>, this diagnosis is excluded.</p>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary failure</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Graves' disease</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">De Quervain's thyroiditis</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Hashimoto's thyroiditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old woman complains of feeling tired all the time and putting on weight. On examination, a diffuse, non-tender goitre is noted. Blood tests are ordered:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240606f2d6d437-0080-4d65-ab9e-ddcf071eb80f.jpg\"><br>What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1188529",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188529,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240606dcd7b9b0-3dfe-4379-a429-2aa45935b96b.jpg\">\n<ul>\n<li><strong>Hashimoto's thyroiditis = hypothyroidism + goitre + anti-TPO</strong></li>\n<li>This patient has <strong>Hashimoto's thyroiditis</strong>, as evidenced by the hypothyroidism, goitre and anti-thyroid peroxidase antibodies. De Quervain's thyroiditis typically causes a painful goitre and a raised ESR.</li>\n<li>Hashimoto's thyroiditis is an <strong>autoimmune disorder of the thyroid gland</strong>. It is typically associated with hypothyroidism, although there may be a transient thyrotoxicosis in the acute phase.</li>\n<li>Clinical features include <strong>hypothyroidism, firm and non-tender goitre</strong>, <strong>positive anti-thyroid peroxidase and also anti-Tg(thyroglobulin) antibodies.</strong></li>\n<li><strong>Grave's disease</strong> is an autoimmune disorder associated with a hyperthyroid state, i.e., Low TSH and high T4 <strong>(Option B ruled out)</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Pituitary failure (Secondary hypothyroidism) (Option A): </strong>In pituitary or hypothalamic disease, TSH is <strong>low or inappropriately normal</strong>, with low T4. Here, TSH is <strong>markedly elevated</strong>, indicating <strong>primary hypothyroidism</strong>, not secondary.</p>\n<p><strong>De Quervain's (Subacute) thyroiditis (Option C): </strong>Presents with <strong>painful, tender goitre</strong>, often after a viral illness. Associated with <strong>elevated ESR</strong> and transient thyrotoxicosis. This patient has a <strong>non-tender goitre</strong>, <strong>normal ESR</strong>, and <strong>positive TPO antibodies</strong>, which point away from De Quervain's.</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Total T4 levels</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Unbound T4 levels</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH and Total T3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Titration of doses of anti-thyroid drugs is best based on?</span></p>",
      "unique_key": "DT1188530",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188530,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Thyroid function tests</strong> and clinical manifestations are reviewed 4-6 weeks after starting treatment, and the dose is titrated based on <strong>unbound T4 levels.</strong></li>\n<li>Most patients do not achieve <strong>euthyroidism</strong> until <strong>6-8 weeks after treatment</strong> is initiated.</li>\n<li><strong>TSH</strong> levels often <strong>remain suppressed for several months</strong> and therefore do not provide a sensitive index of treatment response. <strong>(Option C ruled out)</strong></li>\n<li>When <strong>TSH</strong> suppression is alleviated, TSH levels can also be used to monitor the effectiveness of therapy.</li>\n<li>Though <strong>total T3 and T4</strong> can also be used, free hormones would be the better option. <strong>(Options A and D ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Graves' disease</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxic multinodular goitre</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Solitary toxic nodule</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Excess iodine ingestion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old female is referred to the endocrine clinic for review. She has been suffering from intermittent tachycardias and panic attacks. There is no significant past medical history. She takes several vitamins and mineral supplements, including kelp (a source of Iodine). On examination, there are no eye signs and no goitre. TSH is < 0.05 mU/l, and TSH receptor antibodies are negative.<br>What is the most likely cause of her thyrotoxicosis?</span></p>",
      "unique_key": "DT1188532",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188532,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Kelp is a very rich source of iodine. In patients with <strong>pre-existing thyroid hyperplasia or adenoma</strong>, the ingestion of large amounts of iodine<strong>(Jod-Besedow phenomenon)</strong> may precipitate <strong>thyrotoxicosis</strong>.</li>\n<li>Treatment is <strong>withdrawal of the kelp</strong> with monitoring of thyroid function.</li>\n<li><strong>Thyrotoxicosis affects 2% of women</strong> and 0.2% of men in their lifetimes. Grave's disease is responsible for around 80% of cases of thyrotoxicosis; toxic multinodular goitre is the next commonest cause.</li>\n<li>In this patient, TSH receptor antibodies are negative, ruling out Graves' disease.</li>\n<li>Patients with Graves' disease may be offered radioiodine, if suitable, or a period of medical therapy with antithyroid drugs.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Graves' disease (Option A): </strong>Usually associated with <strong>ophthalmopathy</strong>, diffuse goitre, and <strong>positive TSH receptor antibodies</strong>. Absent in this case, so unlikely.</p>\n<p><strong>Toxic multinodular goitre (Option B): </strong>Presents with an <strong>enlarged, nodular thyroid gland</strong> and clinical thyrotoxicosis. This patient has <strong>no goitre</strong> on examination.</p>\n<p><strong>Solitary toxic nodule (Option C): </strong>Typically presents with a <strong>palpable thyroid nodule</strong> and focal uptake on thyroid scan. No nodule is reported in this case.</p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Riedel's thyroiditis</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaplastic Thyroid carcinoma</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Hashimoto's thyroiditis</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Silent thyroiditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are asked to review a 58-year-old woman who presents with a slowly enlarging hard mass in the anterior neck. Thyroid ultrasound reveals infiltration of the mass into adjacent structures, and biopsy reveals dense fibrous change and no atypical cells. Free T4 is low, and her TSH is markedly raised, consistent with hypothyroidism. Thyroid autoantibodies are negative. Which of the following is the most likely diagnosis given this clinical picture?</span></p>",
      "unique_key": "DT1188534",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188534,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>By the nature of its presentation, <strong>Riedel's thyroiditis</strong> is often confused with thyroid carcinoma, especially the anaplastic variant.</li>\n<li>It is characterised by <strong>marked fibrous infiltration</strong> of the thyroid gland, the aetiology of this being as yet unidentified.</li>\n<li>Treatment is with <strong>thyroxine replacement</strong>.</li>\n<li><strong>Hashimoto's thyroiditis</strong> is autoimmune in aetiology and is characterised by lymphocytic infiltration and the presence of antimicrosomal antibodies(anti-TPO). Graves' disease is associated with thyroid-stimulating autoantibodies and hyperthyroidism.</li>\n<li>Thyroid ultrasound reveals infiltration, but no discrete mass is identified, and biopsy reveals dense fibrous infiltration of the gland.</li>\n<li>If the patient presents with severe compressive symptoms like <strong>dysphagia</strong> and dyspnea, then glucocorticoid therapy is useful.</li>\n<li>Other immunomodulators like mycophenolate and tamoxifen have also been tried.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Anaplastic thyroid carcinoma (Option B): </strong>Rapidly enlarging neck mass, usually in elderly patients, with <strong>atypical malignant cells</strong> on biopsy. Unlike Riedel's, the biopsy shows <strong>malignancy</strong>, not bland fibrosis.</p>\n<p><strong>Hashimoto's thyroiditis (Option C): </strong>Autoimmune disorder with <strong>lymphocytic infiltration</strong>, often positive for <strong>anti-TPO antibodies</strong>. The thyroid is firm but not'woody hard,' and histology shows germinal centres, not dense fibrosis.</p>\n<p><strong>Silent thyroiditis (Option D): </strong>Also called <strong>painless thyroiditis</strong>. Usually transient, with <strong>thyrotoxicosis followed by hypothyroidism</strong>. The thyroid is not rock-hard and does not infiltrate surrounding structures.</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioiodine</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Reassurance and follow-up</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbimazole</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 11-week pregnant woman presents to the hospital with hyperemesis, tremors and persistent tachycardia. Her investigation reports are as follows:<br>TSH: 0.01 mIU/L (0.5-4.5)<br>T4: 19 mcg/dl (5-12)<br>TSH receptor antibodies: positive. Which of the following is the best management step?</span></p>",
      "unique_key": "DT1188536",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188536,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In pregnancy, the two common causes of thyrotoxicosis are <strong>gestational thyrotoxicosis</strong> and <strong>Graves' disease</strong>.</li>\n<li>This patient has <strong>Graves' disease</strong>, as suggested by <strong>positive TSH receptor antibodies</strong>.</li>\n<li><strong>Management in 1st trimester:</strong> <strong>Propylthiouracil</strong> (PTU) is preferred because <strong>carbimazole and methimazole</strong> are associated with congenital malformations (aplasia cutis, choanal/oesophagal atresia). <strong>(Option C ruled out)</strong></li>\n<li>In the <strong>2nd and 3rd trimesters</strong>, therapy is usually switched to <strong>methimazole/carbimazole</strong>, as prolonged PTU use carries a risk of <strong>hepatotoxicity</strong>.</li>\n<li><strong>Radioiodine is contraindicated</strong> in pregnancy because it crosses the placenta and destroys the fetal thyroid. <strong>(Opinion A ruled out)</strong></li>\n<li><strong>Reassurance</strong> alone is not appropriate here, since the antibody positivity and biochemical profile indicate <strong>true Graves' disease</strong>, not transient gestational thyrotoxicosis. <strong>(Option B ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased Pa(O2)</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased Pa (CO2)</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased Pa (CO2)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 44-year-old woman presents to the Emergency Department with palpitations and shortness of breath. Recent thyroid function tests on the hospital computer reveal thyroid-stimulating hormone (TSH) of <0.05 mU/l and a markedly elevated T4. You advise blood gas testing. Which of the following findings would be most consistent with Graves' disease?</span></p>",
      "unique_key": "DT1188539",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188539,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Hyperthyroidism increases <strong>basal metabolic rate</strong> and causes a <strong>hyperdynamic circulation</strong>, leading to increased tissue oxygen demand and CO2 production.</li>\r\n<li>To compensate, patients develop <strong>increased ventilatory drive</strong>, higher tidal volume and minute ventilation.</li>\r\n<li>As a result, they demonstrate <strong>lower resting arterial CO2 tension (PaCO2)</strong> and relatively higher PaO2compared to normal individuals.</li>\r\n<li>These ventilatory changes correlate with <strong>elevated T3 levels</strong>, which stimulate the respiratory centre.</li>\r\n<li>Importantly, this can lead to <strong>misdiagnosis as hyperventilation syndrome</strong> if thyroid status is not considered.</li>\r\n</ul>\r\n<p>Explanation of other options:</p>\r\n<p><strong>Respiratory acidosis (Option A):</strong> Seen in <strong>hypoventilation</strong> or CO2 retention (e.g., COPD, neuromuscular disease), not in hyperthyroidism.</p>\r\n<p><strong>Decreased Pa(O2)</strong> <strong>(Option B):</strong> Hyperthyroid patients usually have <strong>normal or slightly increased PaO2</strong>, due to increased ventilation.</p>\r\n<p><strong>Increased Pa(CO2)</strong> <strong>(Option C):</strong> Opposite finding; hyperthyroidism lowers PaCO2 through hyperventilation.</p>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased lipolysis</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased myocardial oxygen demand</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperprolactinemia</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased bone formation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old woman presents to her GP complaining of palpitations, sweating and weight loss of around 4kg over the past 6 months. She has a history of thyroid disease in the family. On examination, she has a blood pressure of 145/85 mmHg and a pulse of 92/minute. Blood examination was done, and the report is shown below:<br>TSH <0.05 mU/l<br>T4: 17.4 mcg/dl<br>Hb 13.4 g/dl<br>Na+ 140 mmol/l<br>K+ 4.0 mmol/l<br>Creatinine 0.9 mg/dl<br>Which of the following is expected in this patient?</span></p>",
      "unique_key": "DT1188542",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188542,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Thyroid hormones stimulate gluconeogenesis and glycogenolysis</strong> in the liver, thereby enhancing glucose uptake into muscle and accelerating clearance of insulin from circulation.</li>\n<li>In <strong>adipose tissue</strong>, thyroid hormones increase <strong>lipolysis</strong>, leading to elevated free fatty acids.</li>\n<li>These stimulate gluconeogenesis and contribute to insulin resistance.</li>\n<li>Thyrotoxicosis is also associated with <strong>increased myocardial oxygen demand</strong>, sometimes precipitating angina in predisposed patients. <strong>(Option B ruled out)</strong></li>\n<li>Additionally, <strong>thyroxine increases bone resorption</strong> by stimulating osteoclast activity. <strong>(Option D ruled out)</strong></li>\n<li><strong>Hyperprolactinemia</strong> is more commonly seen in <strong>hypothyroidism</strong>, where elevated TRH stimulates prolactin secretion. In hyperthyroidism, TRH is suppressed, so prolactin levels are typically normal or low. <strong>(Option C ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary thyroid carcinoma</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaplastic thyroid carcinoma</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular thyroid carcinoma</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary thyroid carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old man presents to the clinic complaining of a lump in the neck, which becomes particularly more prominent when she swallows. Upon examination, a thyroid nodule is found at the base of the neck. Genetic testing of two other family members who suffered thyroid carcinoma has revealed a mutation in the RET proto-oncogene. Which is the most likely cancer in this patient?</span></p>",
      "unique_key": "DT1188545",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188545,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>RET proto-oncogene</strong> encodes for a receptor tyrosine kinase.</li>\n<li>Activating mutation in the RET gene can lead to <strong>MEN 2A</strong> and <strong>MEN 2B</strong></li>\n<li><strong>Medullary thyroid cancer</strong> is present in 100% of MEN2A and MEN2B syndrome cases.</li>\n<li><strong>Serum Calcitonin</strong> is used as a <strong>tumour marker</strong> in screening patients with suspected Medullary thyroid cancer.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250919920761b5-f84c-421f-9290-6a7bb8dd2cdc.png\">\n<p><strong>Reference:</strong></p>\n<p><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9312840/\" target=\"_blank\">https://pmc.ncbi.nlm.nih.gov/articles/PMC9312840/</a></p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Suppressive treatment with thyroid hormone</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioiodine treatment</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemotherapy</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">External beam radiotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You review a 55-year-old woman in the clinic. She has a thyroid mass, which was diagnosed as lymphoma on core biopsy. Which of the following is the best choice of therapy in this case?</span></p>",
      "unique_key": "DT1188549",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188549,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Primary thyroid lymphoma is a rare malignancy, strongly associated with <strong>Hashimoto's thyroiditis</strong>.</li>\n<li>The tumour is highly radiosensitive, and <strong>external beam radiotherapy (EBRT)</strong> is the mainstay of treatment, especially for localised disease.</li>\n<li>In advanced or disseminated disease, <strong>combined chemo-radiotherapy</strong> may be required, but <strong>EBRT remains the initial choice</strong> for localised thyroid lymphoma.</li>\n</ul>\n<p><strong>Explanation of other options</strong></p>\n<p><strong>Suppressive treatment with thyroid hormone</strong> <strong>(Option A):</strong> Thyroid hormone suppression is used in <strong>differentiated thyroid cancers</strong> (papillary/follicular) to reduce TSH stimulation.</p>\n<p><strong>Radioiodine treatment (Option B):</strong> Radioiodine is effective only in differentiated thyroid carcinomas (papillary, follicular) that uptake iodine. Lymphoma cells <strong>do not concentrate iodine</strong>, making this treatment ineffective.</p>\n<p><strong>Chemotherapy (Option C):</strong> Chemotherapy may be required for <strong>advanced-stage thyroid lymphoma</strong>, especially when there is dissemination or systemic disease. However, in localised disease (as in this case), EBRT is the <strong>preferred first-line therapy</strong>.</p>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary carcinoma with lymph node metastases</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular carcinoma with bone metastases</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaplastic thyroid carcinoma</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old woman with thyroid cancer comes to see you. Which of the following has the worst prognosis in thyroid cancer?</span></p>",
      "unique_key": "DT1188552",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188552,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong></p>\n<ul>\n<li><strong>Anaplastic thyroid carcinoma</strong> accounts for <strong>&lt;2% of thyroid malignancies</strong> but has the <strong>worst prognosis</strong> among all thyroid cancers.</li>\n<li>It is <strong>rapidly progressive</strong>, often presenting with <strong>locally invasive disease</strong> that encases or compresses the trachea, leading to <strong>death by asphyxiation</strong> within months of diagnosis.</li>\n<li>Unlike differentiated thyroid cancers, it is <strong>unresponsive</strong> to surgery, radioiodine, or thyroid hormone suppression.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Papillary carcinoma with lymph node metastases (Option A): </strong>Papillary carcinoma is the <strong>most common thyroid cancer (~70%)</strong>. It spreads to cervical lymph nodes but still has an <strong>excellent prognosis</strong>, especially in younger patients.</p>\n<p><strong>Follicular carcinoma with bone metastases</strong> <strong>(Option B):</strong> Follicular carcinoma (~15% of thyroid cancers) spreads <strong>hematogenously</strong>, often to <strong>bone or lungs</strong>. Prognosis depends on invasiveness and response to radioiodine. Even with distant spread, it is <strong>better than anaplastic carcinoma</strong>.</p>\n<p><strong>Thyroid lymphoma</strong> <strong>(Option D):</strong> Represents <strong>~5%</strong> of thyroid malignancies, usually in older women with Hashimoto's thyroiditis. It is <strong>radiosensitive and chemosensitive</strong>, and prognosis depends on stage and histology, but still <strong>better than anaplastic carcinoma</strong>.</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Atorvastatin</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Gemfibrozil</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Levothyroxine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old female complains of feeling tired all the time. The following laboratory results have been obtained: <br>Cholesterol 324 mg/dl<br>lipoprotein (LDL) 212 mg/dl<br>Thyroid-stimulating<br>hormone (TSH) 92.5 mu/l<br>What is the most appropriate treatment?</span></p>",
      "unique_key": "DT1188556",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188556,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Severe hypothyroidism</strong> is indicated by <strong>very high TSH</strong> with <strong>marked hypercholesterolemia</strong> (increased LDL and total cholesterol).</li>\n<li>The dyslipidemia is <strong>secondary to hypothyroidism</strong>, not primary hyperlipidemia.</li>\n<li>The mechanism includes:\n<ul>\n<li>Decreased<strong> LDL receptor expression</strong>, impaired receptor-mediated LDL clearance.</li>\n<li>Decreased<strong> Lipoprotein lipase activity</strong>, impaired triglyceride clearance.</li>\n<li>HDL may be normal or increased.</li>\n</ul>\n</li>\n<li><strong>Treatment of the underlying hypothyroidism with levothyroxine</strong> corrects both the metabolic symptoms (fatigue) and the lipid abnormalities.</li>\n<li><strong>Statins</strong> or other <strong>lipid-lowering agents</strong> (Ezetimibe and Gemfibrozil) are <strong>not first-line</strong> because correcting hypothyroidism usually normalises the lipid profile. <strong>(Options A, B and C ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Commence low-dose carbimazole therapy</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Commence propylthiouracil therapy</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Observe and repeat thyroid function tests in 1 month</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Start high-dose carbimazole and thyroxine concomitantly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old woman is referred by her family doctor. She is 10 weeks pregnant and complaining of anxiety and an inability to sleep. Total thyroxine (T4) is noted to be 160 nmol/l (normal 70-140)<br>Free T4 is noted to be 27 pmol/l (normal 9-25), thyroid-stimulating hormone (TSH) 0.4 mU/l.<br>Which of the following is the management of choice in this patient?</span></p>",
      "unique_key": "DT1188562",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>During <strong>early pregnancy</strong>, <strong>&beta;-human chorionic gonadotropin (&beta;-hCG)</strong> exerts a <strong>TSH-like effect</strong>, leading to:</li>\n<li><strong>Suppression of TSH</strong> (seen in up to 10% of women in the first trimester).</li>\n<li><strong>Mild, transient rise in free T4 and total T4</strong>.</li>\n<li><strong>A rise in total T4</strong> also reflects increased <strong>thyroxine-binding globulin (TBG)</strong> from high estrogen.</li>\n<li>These changes are <strong>physiological</strong>, not pathological.</li>\n<li>True <strong>maternal hyperthyroidism</strong> (e.g., Graves' disease) is uncommon in pregnancy (~0.2%), and when present, is usually associated with very <strong>suppressed/undetectable TSH</strong> and more <strong>marked FT4 elevation</strong>, often with clinical signs <strong>(goitre, ophthalmopathy).</strong></li>\n<li>In this case, the mild abnormalities do <strong>not warrant antithyroid drugs</strong>.</li>\n<li>Best management is <strong>observation and repeat TFT in 4-6 weeks</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250919ad530927-fa6a-4bd7-bb50-9927a7c3bb16.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Low-dose carbimazole (Option A): Used for true hyperthyroidism, but contraindicated in 1st trimester (risk of aplasia cutis, choanal atresia). Not appropriate here as this is physiological.</strong></p>\n<p><strong>Propylthiouracil (Option B): </strong>Preferred antithyroid drug in <strong>1st trimester of Graves' disease</strong>. Not indicated here as there is <strong>no evidence of Graves'</strong> (TSH not suppressed below normal, no antibodies mentioned, no clinical hyperthyroidism).</p>\n<p><strong>High-dose carbimazole and thyroxine concomitantly (Option D): </strong>Known as the <strong>'block-and-replace' regimen</strong>. Not recommended in pregnancy due to the risk of <strong>fetal hypothyroidism</strong> and is unnecessary in physiological gestational thyrotoxicosis.</p>\n<p><strong>Reference:</strong></p>\n<p><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK559203/?utm_source=chatgpt.com\" target=\"_blank\">https://www.ncbi.nlm.nih.gov/books/NBK559203</a></p>\n<p><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK448195/\" target=\"_blank\">https://www.ncbi.nlm.nih.gov/books/NBK448195/</a></p>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute thyroiditis</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Grave's disease</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxic multinodular goiter</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyrotoxicosis factitia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old pharmacist is admitted to the Emergency Room with a panic attack. On further questioning, it transpires that she has been suffering from palpitations and has lost weight over the past 6 months. Her periods stopped 3 months ago. On examination, her BP is 145/90 mmHg, pulse is 92/min at rest. Her BMI is 20; the remainder of her clinical examination is unremarkable.<br>Investigations: <br>Hb 13.1 g/dl <br>WCC 4.9 x 10^9/L <br>PLT 145 x 10^9/L <br>TSH <0.05 U/l <br>Free T4 32 pmol/l <br>Serum thyroglobulin low <br>Decreased thyroid uptake on scintigraphy scan <br>Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "DT1188566",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188566,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The combination of <strong>low thyroglobulin, decreased uptake on scintigraphy</strong> and <strong>raised T4</strong> is suggestive of <strong>thyrotoxicosis factitia.</strong></li>\n<li><strong>Thyrotoxicosis factitia</strong> results from <strong>exogenous ingestion of thyroid hormone</strong> (intentional or accidental).</li>\n<li>Given the fact that this patient is a pharmacist, she is likely to have <strong>access to thyroid hormone.</strong></li>\n<li><strong>Subacute thyroiditis</strong> will have neck tenderness with reduced uptake in thyroid scintigraphy, but elevated serum thyroglobulin. <strong>(Option A ruled out)</strong></li>\n<li>Thyroid scintiography will show <strong>diffuse uptake</strong> in <strong>Graves' disease,</strong> while <strong>multiple areas of focal uptake</strong> are seen with <strong>toxic MNG. (Options B and C ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioactive iodine therapy</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbimazole</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Surgical excision</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman presents with weight loss, palpitations, diarrhoea and irregular menstrual cycles. Examination reveals a single nodule on the left lobe of her thyroid gland, about 1.5 cm in diameter. Thyroid scanning with technetium shows increased uptake within the nodule with reduced activity throughout the rest of the gland. Thyroid function tests showed a free thyroxine of 30 pmol/l (9-25 pmol/l), TSH < 0.05 mU/l (0.5-5). Based upon these findings, what would be the definitive treatment?</span></p>",
      "unique_key": "DT1188609",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188609,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The clinical picture is consistent with a <strong>toxic (autonomous) thyroid nodule</strong>.</li>\n<li>Such nodules preferentially take up <strong>radioactive iodine (RAI)</strong> and are highly amenable to treatment with it.</li>\n<li>A dose of <strong>300-500 MBq</strong> is usually sufficient to ablate the nodule and cure the thyrotoxicosis.</li>\n<li><strong>RAI is contraindicated</strong> in pregnancy, lactation, and in children. In such cases, <strong>surgical excision (lobectomy/hemithyroidectomy)</strong> is the next best option. <strong>(Option C ruled out)</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Carbimazole (Option B): </strong>Antithyroid drugs can control hyperthyroidism <strong>temporarily</strong> but are not definitive therapy for toxic nodules. More useful in <strong>Graves' disease</strong>.</p>\n<p><strong>Propranolol (Option D): </strong>Provides <strong>symptomatic relief</strong> (tachycardia, tremor, anxiety) but does <strong>not affect the underlying cause</strong>. Often used as a bridging therapy until definitive treatment.</p>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">CXR</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid ultrasound</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">X-ray of thoracic inlet</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Chest</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 44-year-old woman presents with a mass in her neck and symptoms of choking/ shortness of breath when she lies down.<br>Investigations; <br>Hb 14.1 g/dl <br>WCC 5.4 x 10^9/L <br>PLT 235 x 10^9/L <br>Na+ 140 mmol/l <br>K+ 4.5 mmol/l <br>Creatinine 0.6 mg/dl <br>TSH 0.9 U/l <br>You suspect that she may have retrosternal extension of the goitre. <br>Which of the following would be the investigation of choice for this patient to determine the degree of retrosternal involvement?</span></p>",
      "unique_key": "DT1188612",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188612,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>CT Chest</strong> is the <strong>most sensitive and specific imaging modality</strong> for evaluating the extent of retrosternal goitre and its compressive effect on adjacent structures (trachea, great vessels, oesophagus).</li>\n<li>It accurately delineates the degree of <strong>mediastinal extension</strong>, displacement, and compression, which is crucial for surgical planning.</li>\n<li>MRI can also be used, but CT is generally preferred for its availability and detail.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>CXR (Option A): </strong>May show <strong>mediastinal mass, tracheal deviation, or compression</strong>, but is less sensitive than CT. Cannot accurately define the <strong>extent</strong> of retrosternal involvement.</p>\n<p><strong>Thyroid ultrasound (Option B): </strong>Excellent for evaluating <strong>thyroid nodules</strong> and cervical thyroid volume. Limited for retrosternal extension because <strong>ultrasound cannot penetrate the sternum</strong>.</p>\n<p><strong>X-ray of thoracic inlet (Option C): </strong>Obsolete and of limited diagnostic value.<br /> Provides poor anatomic detail compared with CT.</p>",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">DeQuervain's thyroiditis</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular carcinoma</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Hashimoto's thyroiditis</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Grave's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old woman complaining of a 4-kg weight gain, dry hair and skin, feels slow and always has the heating up high fever. She has a small diffuse goitre. Her TSH level is 20 mU/l. Thyroid peroxidase antibody is positive at high titres. She has two sisters who have had thyroid disease. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1188615",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188615,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Hashimoto's thyroiditis</strong> is the <strong>most common cause of hypothyroidism</strong> in iodine-sufficient regions.</li>\n<li>It is an <strong>autoimmune disorder</strong> characterised by:\n<ul>\n<li><strong>High titers of thyroid peroxidase (TPO) and thyroglobulin antibodies</strong></li>\n<li><strong>Diffuse, firm goitre</strong> (not multinodular)</li>\n<li><strong>Female predominance</strong> with family clustering (autoimmune tendency)</li>\n</ul>\n</li>\n<li>Histology: <strong>lymphocytic infiltration with germinal centres</strong>, H&uuml;rthle cell change, and fibrosis.</li>\n<li>Clinical presentation is typically <strong>hypothyroidism</strong> (fatigue, weight gain, cold intolerance, dry skin, hair loss).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>De Quervain's thyroiditis (Option A): Subacute, painful thyroiditis</strong>, often post-viral, with tender goitre. Associated with <strong>high ESR</strong> and a transient thyrotoxic phase. <strong>Not antibody-positive</strong>.</p>\n<p><strong>Follicular carcinoma (Option B): </strong>Malignant neoplasm of follicular cells. Presents as a <strong>solitary thyroid nodule</strong>, usually euthyroid. Not associated with autoantibodies or hypothyroidism.</p>\n<p><strong>Graves' disease (Option D): </strong>Autoimmune disorder with <strong>TSH receptor-stimulating antibodies</strong>, leading to <strong>hyperthyroidism</strong>. Presents with diffuse goitre, ophthalmopathy, and pretibial myxedema. Opposite biochemical picture (<strong>low TSH, high T4</strong>).</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum TSH</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum calcitonin</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">24-h urine test for 5-hydroxyindoleacetic acid</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">24-hour urinary metanephrines</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old woman presents with recurrent episodes of headaches and sweating. Her mother had renal calculi and died of a tumour in her neck. On examination, a nodule is felt in the patient's neck in the region of the thyroid gland. A surgeon advises complete thyroidectomy.<br>What is the most important investigation the surgeon must undertake before surgery?</span></p>",
      "unique_key": "DT1188618",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188618,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The clinical scenario is strongly suggestive of <strong>Medullary carcinoma of the thyroid (MTC)</strong>.</li>\n<li>MTC arises from <strong>parafollicular C cells</strong> and secretes <strong>calcitonin</strong>.</li>\n<li>It often occurs as part of <strong>MEN-2A syndrome</strong>:\n<ul>\n<li><strong>M</strong>edullary carcinoma thyroid</li>\n<li><strong>P</strong>arathyroid hyperplasia</li>\n<li><strong>P</strong>heochromocytoma</li>\n</ul>\n</li>\n<li>In patients with suspected MEN-2, it is <strong>critical to exclude pheochromocytoma before thyroidectomy</strong>.</li>\n<li>If pheochromocytoma is present, manipulation during thyroid surgery can precipitate a <strong>hypertensive crisis</strong> due to catecholamine surge.</li>\n<li>Screening is done with <strong>24-hour urinary fractionated metanephrines (or plasma metanephrines)</strong>.</li>\n<li>If pheochromocytoma is detected, it must be managed <strong>before thyroid surgery</strong> with alpha-adrenergic blockade.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Serum TSH (Option A): </strong>Normal in MTC; not useful for surgical planning. TSH suppression is relevant for papillary/follicular carcinoma follow-up, not MTC.</p>\n<p><strong>Serum calcitonin (Option B): </strong>Elevated in MTC and useful for <strong>diagnosis and follow-up</strong>. However, preoperative priority is to rule out pheochromocytoma, as it poses an immediate <strong>perioperative risk</strong>.</p>\n<p><strong>24-hour urine 5-HIAA (Option C): </strong>Used for diagnosing <strong>carcinoid syndrome</strong>, not MTC or MEN-2.</p>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaplastic thyroid cancer</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular thyroid cancer</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary thyroid cancer</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 81-year-old woman is referred to the thyroid clinic with an increasing size of a pre-existing goitre. She has had long-standing hypothyroidism due to Hashimoto's thyroiditis and has been on a dose of thyroxine of 100 mg daily for many years. Which of the following primary thyroid cancers is she most likely to have?</span></p>",
      "unique_key": "DT1188626",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188626,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Primary thyroid lymphoma</strong> is a rare thyroid malignancy but is <strong>strongly associated with Hashimoto's thyroiditis</strong> (present in ~80% of cases).</li>\n<li>It predominantly affects <strong>elderly women</strong> with a history of autoimmune thyroid disease.</li>\n<li>Patients often have a <strong>long-standing goitre</strong> that suddenly enlarges, sometimes causing <strong>compressive symptoms</strong> (dyspnea, dysphagia, hoarseness).</li>\n<li>It is important to differentiate thyroid lymphoma from <strong>anaplastic carcinoma</strong>, as lymphoma is <strong>highly radiosensitive and chemosensitive</strong>, whereas anaplastic carcinoma is rapidly fatal.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Anaplastic thyroid cancer (Option A): </strong>Occurs in elderly patients, presenting with a <strong>rapidly enlarging, hard neck mass</strong>. Very aggressive with the <strong>worst prognosis</strong> among thyroid cancers. Not specifically associated with Hashimoto's thyroiditis.</p>\n<p><strong>Follicular thyroid cancer (Option B): </strong>Typically affects <strong>middle-aged to older adults</strong>, often presenting as a <strong>solitary nodule</strong>. Spreads hematogenously (bone, lung). Not linked to autoimmune thyroid disease.</p>\n<p><strong>Medullary thyroid cancer (Option C): </strong>Arises from <strong>parafollicular C cells</strong>, secreting <strong>calcitonin</strong>. It can be sporadic or part of the <strong>MEN-2 syndrome</strong>. No association with Hashimoto's thyroiditis.</p>",
      "correct_choice_id": 184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Laryngeal nerve palsy</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoparathyroidism</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Recurrent hyperthyroidism</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old man with Graves' disease is being considered for subtotal thyroidectomy. What is the most common postoperative complication following this operation?</span></p>",
      "unique_key": "DT1188629",
      "question_audio": null,
      "question_video": null,
      "map_id": 1188629,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>After <strong>subtotal thyroidectomy</strong> for Graves&rsquo; disease, the most common long-term complication is <strong>hypothyroidism</strong>.</li>\n<li>Incidence:\n<ul>\n<li>~10% within the first year</li>\n<li>Progressively increases with time: a <strong>majority eventually develop hypothyroidism.</strong></li>\n</ul>\n</li>\n<li>The risk is due to loss of sufficient functioning thyroid tissue after surgery.</li>\n<li>Lifelong thyroid hormone replacement is often required.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Laryngeal nerve palsy (Option A): </strong>Injury to the <strong>recurrent laryngeal nerve</strong> causes hoarseness and vocal cord paralysis. Occurs in ~1% of cases, far less common than hypothyroidism.</p>\n<p><strong>Hypoparathyroidism (Option B): </strong>Results from accidental removal or devascularization of the parathyroid glands. Transient hypocalcemia may occur in up to 10%, but <strong>permanent hypoparathyroidism is &lt;1%</strong>.</p>\n<p><strong>Recurrent hyperthyroidism (Option C): </strong>Recurrence occurs in ~1-3% within the first year, and ~1% per year thereafter. Much less frequent than postoperative hypothyroidism.</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}